| Cat. No. |
Product Name |
Information |
| PC-25034 |
TUL01101
JAK1 inhibitor
|
Blovacitinib (TUL01101) is a potent, selective and oral Janus kinase 1 (JAK1) inhibitor with IC50 of 3 nM, >12-fold selectivity for JAK2 and TYK2. |
| PC-24937 |
Cenacitinib
TYK2 inhibitor
|
Cenacitinib (VTX 958) is a potent, highly selective, allosteric and orally bioavailable inhibitor of tyrosine kinase 2 (TYK2). |
| PC-24735 |
NMS-P953
JAK2 inhibitor
|
NMS-P953 is a potent and selective JAK2 inhibitor with IC50 of 8 nM, displays 18-, 4- and 18-fold selective over JAK1, JAK3 and TYK2 respectively. |
| PC-24348 |
cTYK2i Compound-A
TYK2 inhibitor
|
cTYK2i Compound-A (Cmpd-A) is a potent, specific and brain-penetrant TYK2 inhibitor (cTYK2i) with IC50 of 6.4 nM. |
| PC-24191 |
Tofacitinib etocomil
JAK inhibitor
|
Tofacitinib etocomil (MH004) is a is a topical product containing a JAK inhibitor tofacitinib, shows extensive target inhibition in local skin tissues without systemic toxicities, has potential for multiple dermatologic autoimmune diseases. |
| PC-24170 |
Plodicitinib
JAK3/TEC kinase inhibitor
|
Plodicitinib is a highly potent, dual inhibitor of JAK3 kinase and BTK kinase with IC50 of 0.3 nM and 2.4 nM, respectively. |
| PC-24155 |
Milpecitinib
JAK inhibitor
|
Milpecitinib is potent, selective Janus tyrosine kinase (JAK) inhibitor. |
| PC-24148 |
Lirucitinib hydrochloride
JAK inhibitor
|
Lirucitinib hydrochloride is a potent, selective JAK inhibitor. |
| PC-24147 |
Lirucitinib
JAK inhibitor
|
Lirucitinib is a potent, selective JAK inhibitor. |
| PC-23784 |
Dual JAK3-TEC kinase inhibitor ZZB
JAK3/TEC kinase inhibitor
|
Dual JAK3-TEC kinase inhibitor ZZB is a potent, selective, covalent dual JAK3/TEC family kinases inhibitor with IC50 of 0.80 nM against JAK3 and 11.56 nM against TEC kinase interleukin-2-inducible T-cell kinase (ITK) respectively. |
| PC-22994 |
SB1578
JAK2/FLT3 inhibitor
|
SB1578 is a potent, selective JAK2/FLT3 inhibitor with IC50 of 46/60 nM respectively. |
| PC-22718 |
Coumermycin A1
JAK2 agonist
|
Coumermycin A1 (C-A1) is a small molecule JAK2 agonist that induces dimerization and activation of JAK2, also inhibits DNA Gyrase and cell division in bacteria. |
